Search

everythinglearnresearchcommunity

for

Search:↓

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Innovative methods are reducing animal testing and improving biomedical research.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.